Latest SABBY MANAGEMENT, LLC Stock Portfolio
SABBY MANAGEMENT, LLC Performance:
2024 Q3: -36.2%YTD: -58.02%2023: -61.78%
Performance for 2024 Q3 is -36.2%, and YTD is -58.02%, and 2023 is -61.78%.
About SABBY MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, SABBY MANAGEMENT, LLC reported an equity portfolio of $186.4 Billions as of 30 Sep, 2024.
The top stock holdings of SABBY MANAGEMENT, LLC are VANI, VLCN, . The fund has invested 1.3% of it's portfolio in VIVANI MEDICAL INC and 0.4% of portfolio in VOLCON INC.
The fund managers got completely rid off CORE SCIENTIFIC, REDHILL BIOPHARMA LTD (RDHL) and GREENWAVE TECHNOLOGY (GWAV) stocks. They significantly reduced their stock positions in EFFECTOR THERAPEUTICS (EFTR), SIDUS SPACE INC (SIDU) and AMPLITECH GROUP INC (AMPG). SABBY MANAGEMENT, LLC opened new stock positions in VOLCON INC (VLCN), HEALTHY CHOICE WELLNESS CORP and IMUNON INC (CLSN). The fund showed a lot of confidence in some stocks as they added substantially to ENSYSCE BIOSCIENCES INC (ENSC), AVENUE THERAPEUTICS INC (ATXI) and VIVANI MEDICAL INC (VANI).
The top stock holdings of SABBY MANAGEMENT, LLC are VANI, VLCN, . The fund has invested 1.3% of it's portfolio in VIVANI MEDICAL INC and 0.4% of portfolio in VOLCON INC.
The fund managers got completely rid off CORE SCIENTIFIC, REDHILL BIOPHARMA LTD (RDHL) and GREENWAVE TECHNOLOGY (GWAV) stocks. They significantly reduced their stock positions in EFFECTOR THERAPEUTICS (EFTR), SIDUS SPACE INC (SIDU) and AMPLITECH GROUP INC (AMPG). SABBY MANAGEMENT, LLC opened new stock positions in VOLCON INC (VLCN), HEALTHY CHOICE WELLNESS CORP and IMUNON INC (CLSN). The fund showed a lot of confidence in some stocks as they added substantially to ENSYSCE BIOSCIENCES INC (ENSC), AVENUE THERAPEUTICS INC (ATXI) and VIVANI MEDICAL INC (VANI).
SABBY MANAGEMENT, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that SABBY MANAGEMENT, LLC made a return of -36.2% in the last quarter. In trailing 12 months, it's portfolio return was -66.88%.
New Buys
| Ticker | $ Bought |
|---|---|
| volcon inc | 805,552,000 |
| healthy choice wellness corp | 754,161,000 |
| imunon inc | 644,695,000 |
| core scientific inc | 403,252,000 |
| pineapple energy inc | 372,688,000 |
| scorpius hldgs inc | 249,304,000 |
| elevai labs inc | 210,968,000 |
| senestech inc | 143,549,000 |
New stocks bought by SABBY MANAGEMENT, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ensysce biosciences inc | 269 |
| avenue therapeutics inc | 68.64 |
| vivani medical inc | 0.09 |
Additions to existing portfolio by SABBY MANAGEMENT, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| effector therapeutics | -82.46 |
| sidus space inc | -63.78 |
| amplitech group inc | -40.68 |
| wearable devices ltd | -33.34 |
| 60 degrees | -8.28 |
SABBY MANAGEMENT, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| redhill biopharma ltd | -497,179,000 |
| aptevo therapeutics inc | -153,459,000 |
| inmed pharmaceuticals inc | -81,571,000 |
| gevo inc | -139,300,000 |
| sonnet biotherapeutics hldng inc | -223,495,000 |
| reviva pharmaceutcls hldgs inc | -303,356,000 |
| greenwave technology | -406,165,000 |
| core scientific | -762,073,000 |
SABBY MANAGEMENT, LLC got rid off the above stocks
Sector Distribution
SABBY MANAGEMENT, LLC has about 56.1% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 56.1 |
| Healthcare | 13.6 |
| Consumer Cyclical | 11.2 |
| 8.9 | |
| Technology | 7.1 |
| Basic Materials | 2 |
| Industrials | 1.2 |
Market Cap. Distribution
SABBY MANAGEMENT, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 56.1 |
| NANO-CAP | 43.9 |
Stocks belong to which Index?
About 0% of the stocks held by SABBY MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 100 |
SABBY MANAGEMENT, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SABBY MANAGEMENT, LLC
SABBY MANAGEMENT, LLC has 27 stocks in it's portfolio. About 3.4% of the portfolio is in top 10 stocks. PEGY proved to be the most loss making stock for the portfolio. SIDU was the most profitable stock for SABBY MANAGEMENT, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AMPG | amplitech group inc | 0.00 | 197,378 | 7,895,000 | reduced | -40.68 | ||
| APDN | applied dna sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APVO | aptevo therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXI | avenue therapeutics inc | 0.08 | 63,060 | 157,019,000 | added | 68.64 | ||
| BIVI | biovie inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BJDX | bluejay diagnostics inc | 0.02 | 305,224 | 38,763,000 | new | |||
| BVXV | biondvax pharmaceuticals ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CHNR | china natural resources inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CING | cingulate inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLSN | imunon inc | 0.35 | 608,203 | 644,695,000 | new | |||
| EFTR | effector therapeutics | 0.00 | 61,758 | 2,285,000 | reduced | -82.46 | ||
| ENSC | ensysce biosciences inc | 0.15 | 1,162,590 | 279,022,000 | added | 269 | ||
| FCUV | focus universal inc | 0.07 | 500,798 | 132,211,000 | new | |||
| GEVO | gevo inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GWAV | greenwave technology | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IJR | ishares tr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INM | inmed pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| KPRX | kiora pharmaceuticals inc | 0.01 | 5,000 | 18,300,000 | new | |||
| LIPO | lipella pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| NEXI | neximmune inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||